TIBET PHARMA (600211.SH) Financial Statements - Balance Sheet/Income Statement/Cash Flow - Longbridge

Quote List Quote List

Event Tracking

Oct30

Tibet Pharma released FY2025 9 Months Earnings on October 30 After-Market (BJT), actual revenue CNY 2.089 B, actual EPS CNY 2.2392

01:00

TIBET PHARMA released FY2025 Q3 earnings on October 30 After-Market (BJT), actual revenue CNY 438.57 M, actual EPS CNY 0.4797

01:00

Oct23

TIBET PHARMA to Release FY2025 Q3 Earnings on October 31 After-Market (BJT)

00:50

Aug15

TIBET PHARMA released FY2025 Semi-Annual Earnings on August 15 During-Market (BJT), Actual Revenue: CNY 1.651 B, Actual EPS: CNY 1.76

01:00

TIBET PHARMA released FY2025 Q2 earnings on August 15 During-Market BJT, actual revenue CNY 938.6 M, actual EPS CNY 0.9195

01:00

Aug8

Tibet Pharma to Release FY2025 Semi-Annual Earnings on August 16, 2025 (BJT)

00:14

Schedules & Filings

Schedules

Filings

Oct30

Earning Release(CST)

FY2025 Q3 Earning Release (CNY) Revenue 438.57 M, Net Income 154.45 M, EPS 0.4797

Sep1

Distribution Plan(CST)

Cash dividend 0.881 CNY

Distribution Plan(CST)

Cash dividend 0.881 CNY

View More

Stock List

Top Gainers

Top Decliners

Northbound Connect

Symbol

Price

%Chg

Change

View More